Zimmer Biomet Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 hits record high as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Burry doubles down on Nebius short after stock surges 34% on earnings
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Home Depot CEO Ted Decker takes medical leave; two executives step in
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Zimmer Biomet (ZBH) PT Raised to $153 at Needham & Company; Buy on Weakness
April 27, 2017 1:46 PM EDTNeedham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $151.00) while maintaining a Strong Buy rating but said disappointing Q1 results return the stock to a "show-me story" but they are recommending investors buy on today's weakness.
Analyst Mike... More
Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 2c; Narrows Outlook
April 27, 2017 7:37 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $2.13, $0.02 better than the analyst estimate of $2.11. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.
"Zimmer Biomet delivered first quarter revenue and adjusted earnings growth consistent with our... More
